Skip to main content
Springer logoLink to Springer
. 2021 Aug 27;26(11):2085–2086. doi: 10.1007/s10147-021-02008-5

Correction to: Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma

Motohide Uemura 1, Noboru Nakaigawa 2, Naoto Sassa 3,14, Katsunori Tatsugami 4,15, Kenichi Harada 5, Toshinari Yamasaki 6, Nobuaki Matsubara 7, Takuya Yoshimoto 8, Yuki Nakagawa 8, Tamaki Fukuyama 9, Mototsugu Oya 10, Nobuo Shinohara 11, Hirotsugu Uemura 12,, Toyonori Tsuzuki 13
PMCID: PMC8523015  PMID: 34449010

Correction to: International Journal of Clinical Oncology https://doi.org/10.1007/s10147-021-01993-x

The article Prognostic value of programmed death‑ligand 1 status in Japanese patients with renal cell carcinoma, written by Motohide Uemura, Noboru Nakaigawa, Naoto Sassa, Katsunori Tatsugami, Kenichi Harada, Toshinari Yamasaki, Nobuaki Matsubara, Takuya Yoshimoto, Yuki Nakagawa, Tamaki Fukuyama, Mototsugu Oya, Nobuo Shinohara, Hirotsugu Uemura, and Toyonori Tsuzuki was originally published Online First without Open Access.

With the author(s)’ decision to opt for Open Choice the copyright of the article changed on August 18, 2021 to © Author(s) 2021 and the article is forthwith distributed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0.

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from International Journal of Clinical Oncology are provided here courtesy of Springer

RESOURCES